Article: Vivra Asthma & Allergy Agrees with Major Study Findings on Long-Term Benefits of Allergy Shots.

PLANTATION, Fla., Aug. 13 /PRNewswire/ -- Vivra Asthma & Allergy, Inc., the nation's largest and preeminent provider of chronic respiratory care, notes that its own experience in treating allergy patients mirrors the findings of a ground-breaking new study published in today's New England Journal of Medicine.

The study, conducted by researchers at the Imperial College School of Medicine in London, provides original and compelling evidence that allergy shots effectively control the symptoms of hay fever sufferers (who constitute approximately 20% of the U.S. population) for years after the shots end.

Allergy patients who received immunotherapy (as shot ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!